Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Auto Casualty
Article
Balanced Regulatory Environment: A Key Component to Unlocking the Value of Specialty Bill Review
Without the use of Specialty Bill Review (SBR), payers risk paying for errors or abuses created by providers with problematic billing practices.
Workers' Comp
Article
Ask The Pharmacist: Understanding Skeletal Muscle Relaxants in Workers' Compensation
What should I know about skeletal muscle relaxants in the treatment of injuries? Skeletal muscle relaxants a
Workers' Comp
Podcast
Demystifying the Nuances of Specialty Bill Review Regulations
Workers' Comp
Article
Safeguarding Medicare's Interests: Strategies and Updates
With increasing regulations surrounding Medicare compliance, it is critical for claims professionals to stay up-to-date on the latest Medicare Set-
Workers' Comp
Case Study
Utilizing Medical Insights to Strengthen Settlement Accuracy on High-Stakes Claims
Mitchell
News Release
Mitchell’s Debbie Day Wins 2024 Top Tech Executive of the Year Award
SAN DIEGO, Calif.—Mitchell, an Enlyte company and leading technology and information provider for the